Table 1.
Baseline characteristics for controls and patients with COVID-19, grouped by symptom severity.
| Variable |
COVID-19 negative controls1 N = 30 |
COVID-19 positive | ||||
|---|---|---|---|---|---|---|
|
Mild or no symptoms2 N = 38 |
Severe acute symptoms3 N = 33 |
MIS-C4 N = 31 |
p-Value | Multiple comp* | ||
| Sex, no. (%) | ||||||
| Female | 20 (67%) | 21 (55%) | 21 (55%) | 14 (42%) | 0.209 | All equal |
| Male | 10 (33%) | 17 (45%) | 17 (45%) | 19 (58%) | ||
| Age, years, | 2.5 (1.0–13.0) |
8.0 (2.0–16.0) |
14.0 (4.0–17.0) |
8.0 (5.0–13.0) |
0.007 | 1 < 3 |
| Median (IQR) | ||||||
| Race/Ethnicity no. (%) | ||||||
| NonHispanic Black | 20 (67%) | 13 (34%) | 12 (36%) | 13 (42%) | 0.013 | 1≠ 2 & 3 |
| Hispanic Other Race | 4 (13%) | 17 (45%) | 15 (45%) | 13 (42%) | ||
| NonHispanic White | 0 (0%) | 4 (11%) | 1 (3%) | 2 (6%) | ||
| NonHispanic Asian | 0 (0%) | 0 (0%) | 0 (0%) | 1 (3%) | ||
| NonHispanic unknown | 6 (20%) | 4 (11%) | 5 (15%) | 2 (6%) | ||
| Underlying diagnoses, no. (%) | ||||||
| Any preexisting condition | N/A | 16 (41%) | 28 (85%) | 1 (3%) | <0.001 | 4 < 2 < 3 |
IQR, interquartile range; kg/m2, kilograms per meter2; MIS-C, multisystem inflammatory syndrome of children; N, number of participants; no., number of a categorical variable; N/A, no data available.
*
Multiple comparisons. Bonferroni adjusted p-values for six comparisons < 0.0083.